BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25009786)

  • 1. Retroviral-infection increases tumorigenic potential of MDA-MB-231 breast carcinoma cells by expanding an aldehyde dehydrogenase (ALDH1) positive stem-cell like population.
    Wegman-Points LJ; Teoh-Fitzgerald ML; Mao G; Zhu Y; Fath MA; Spitz DR; Domann FE
    Redox Biol; 2014; 2():847-54. PubMed ID: 25009786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.
    Ginestier C; Hur MH; Charafe-Jauffret E; Monville F; Dutcher J; Brown M; Jacquemier J; Viens P; Kleer CG; Liu S; Schott A; Hayes D; Birnbaum D; Wicha MS; Dontu G
    Cell Stem Cell; 2007 Nov; 1(5):555-67. PubMed ID: 18371393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.
    Charafe-Jauffret E; Ginestier C; Iovino F; Tarpin C; Diebel M; Esterni B; Houvenaeghel G; Extra JM; Bertucci F; Jacquemier J; Xerri L; Dontu G; Stassi G; Xiao Y; Barsky SH; Birnbaum D; Viens P; Wicha MS
    Clin Cancer Res; 2010 Jan; 16(1):45-55. PubMed ID: 20028757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological analysis of breast ductal carcinoma in situ with ALDH1-positive cancer stem cells.
    Tsukabe M; Shimazu K; Morimoto K; Naoi Y; Kagara N; Shimoda M; Shimomura A; Maruyama N; Kim SJ; Noguchi S
    Oncology; 2013; 85(4):248-56. PubMed ID: 24192633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aldehyde dehydrogenase 1 can be used as a new marker of cancer stem cells in laryngeal cancer cells in vitro].
    Jin X; Zhao Y; Qian J; Tang J; Zhan XD
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):900-4. PubMed ID: 22340098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma.
    Lohberger B; Rinner B; Stuendl N; Absenger M; Liegl-Atzwanger B; Walzer SM; Windhager R; Leithner A
    PLoS One; 2012; 7(8):e43664. PubMed ID: 22928012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.
    Jiang F; Qiu Q; Khanna A; Todd NW; Deepak J; Xing L; Wang H; Liu Z; Su Y; Stass SA; Katz RL
    Mol Cancer Res; 2009 Mar; 7(3):330-8. PubMed ID: 19276181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide.
    Kim SH; Kaschula CH; Priedigkeit N; Lee AV; Singh SV
    J Biol Chem; 2016 Jun; 291(26):13495-508. PubMed ID: 27129776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women.
    Schwartz T; Stark A; Pang J; Awuah B; Kleer CG; Quayson S; Kingman S; Aitpillah F; Abantanga F; Jiagge E; Oppong JK; Osei-Bonsu E; Martin I; Yan X; Toy K; Adjei E; Wicha M; Newman LA
    Cancer; 2013 Feb; 119(3):488-94. PubMed ID: 22930220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-expression of stem cell markers ALDH1 and CD44 in non-malignant and neoplastic lesions of the breast.
    DA Cruz Paula A; Marques O; Rosa AM; DE Fátima Faria M; Rêma A; Lopes C
    Anticancer Res; 2014 Mar; 34(3):1427-34. PubMed ID: 24596390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemin stimulates radio- and chemo-resistance by promoting TWIST1-BCL-2-dependent cancer stem cell-like behavior in mammary carcinoma cells.
    Banerjee A; Qian P; Wu ZS; Ren X; Steiner M; Bougen NM; Liu S; Liu DX; Zhu T; Lobie PE
    J Biol Chem; 2012 Dec; 287(51):42502-15. PubMed ID: 23095743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line.
    Ueda K; Ogasawara S; Akiba J; Nakayama M; Todoroki K; Ueda K; Sanada S; Suekane S; Noguchi M; Matsuoka K; Yano H
    PLoS One; 2013; 8(10):e75463. PubMed ID: 24116047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of STAT3 signaling in ALDH+ and ALDH+/CD44+/CD24- subpopulations of breast cancer cells.
    Lin L; Hutzen B; Lee HF; Peng Z; Wang W; Zhao C; Lin HJ; Sun D; Li PK; Li C; Korkaya H; Wicha MS; Lin J
    PLoS One; 2013; 8(12):e82821. PubMed ID: 24376586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species.
    Mizuno T; Suzuki N; Makino H; Furui T; Morii E; Aoki H; Kunisada T; Yano M; Kuji S; Hirashima Y; Arakawa A; Nishio S; Ushijima K; Ito K; Itani Y; Morishige K
    Gynecol Oncol; 2015 May; 137(2):299-305. PubMed ID: 25541259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased sensitivity of African American triple negative breast cancer cells to nitric oxide-induced mitochondria-mediated apoptosis.
    Martinez L; Thames E; Kim J; Chaudhuri G; Singh R; Pervin S
    BMC Cancer; 2016 Jul; 16():559. PubMed ID: 27473585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics.
    Li D; Zhang T; Gu W; Li P; Cheng X; Tong T; Wang W
    Oncol Rep; 2015 May; 33(5):2291-8. PubMed ID: 25760144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity.
    Lohberger B; Stuendl N; Wolf E; Liegl-Atzwanger B; Leithner A; Rinner B
    BMC Cancer; 2013 Dec; 13():563. PubMed ID: 24289252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.
    Miyoshi Y; Shien T; Ogiya A; Ishida N; Yamazaki K; Horii R; Horimoto Y; Masuda N; Yasojima H; Inao T; Osako T; Takahashi M; Tomioka N; Endo Y; Hosoda M; Doihara H; Miyoshi S; Yamashita H;
    Breast Cancer Res; 2016 Jul; 18(1):73. PubMed ID: 27368476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype.
    Zhong Y; Shen S; Zhou Y; Mao F; Guan J; Lin Y; Xu Y; Sun Q
    Med Oncol; 2014 Mar; 31(3):864. PubMed ID: 24519209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
    Li W; Ma H; Zhang J; Zhu L; Wang C; Yang Y
    Sci Rep; 2017 Oct; 7(1):13856. PubMed ID: 29062075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.